Straits Times Index
3,303.26 -10.79 (-0.33%) S&P 500
5,308.13 +4.86 (+0.09%) Dow
39,806.77 -196.82 (-0.49%) Nasdaq
16,794.88 +108.91 (+0.65%) Bitcoin USD
71,031.99 +4,126.59 (+6.17%) CMC Crypto 200
1,524.81 +36.27 (+2.44%)
The Trendlines Group Ltd. (42T.SI)
- PR Newswire
Limaca Medical Completes 24 EUS Pancreatic and Liver Biopsy Cases
Limaca Medical ("Limaca") announced today the successful completion of twenty-four Precision-GI™ endoscopic ultrasound guided motorized fine needle biopsy (EUS-mFNB) cases. Precision-GI's motorized rotational cutting needle demonstrated significant tissue acquisition. Cases completed by Dr. Carlos Robles-Medranda and colleagues in the ongoing study demonstrate that Precision-GI is quickly and efficiently obtaining contiguous intact core tissue samples for definitive diagnosis of target tissues.
- PR Newswire
ZygoFix Receives FDA Clearance for its zLOCK Lumbar Facet Fixation System
ZygoFix Ltd. a portfolio company of The Trendlines Group Ltd. ("Trendlines") announced that it received regulatory clearance from the United States Food and Drug Administration (FDA clearance) for its zLOCK Lumbar Facet Fixation System. This achievement was supported by compelling clinical evidence from the company's ongoing European clinical study, marking a significant advancement in spinal fusion technology.
- PR Newswire
Arcuro Medical Appoints Jamal Rushdy CEO
Arcuro Medical Ltd. (www.arcuromedical.com), a portfolio company of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), today announced the appointment of MedTech industry veteran Jamal Rushdy as Chief Executive Officer.
